# Concurrent Once Daily Versus Twice Daily Radiotherapy for Limited Stage Small Cell Lung Cancer

> **NCT00433563** · NA · COMPLETED · sponsor: **The Christie NHS Foundation Trust** · enrollment: 547 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **RADIATION:** Once daily radiotherapy
- **RADIATION:** Twice daily radiotherapy

## Key facts

- **NCT ID:** NCT00433563
- **Lead sponsor:** The Christie NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2016-02
- **Final completion:** 2019-01
- **Target enrollment:** 547 (ACTUAL)
- **Last updated:** 2022-09-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00433563

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00433563, "Concurrent Once Daily Versus Twice Daily Radiotherapy for Limited Stage Small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00433563. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*